Smith & Nephew

Smith & Nephew

Makes Truclear, a product that removes polyps, fibroids and other abnormal tissue from the uterus.

Launch date
Employees
Market cap
CAD18.5b
Enterprise valuation
CAD22.8b (Public information from Sep 2024)
Company register number 00324357
Watford England (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD2020202120222023202420252026
Revenues4.6b5.2b5.2b5.5b5.8b6.1b6.4b
% growth(11 %)14 %-6 %5 %5 %5 %
EBITDA904m1.2b943m1.2b1.4b1.6b1.7b
% EBITDA margin20 %22 %18 %21 %25 %26 %27 %
Profit448m524m223m263m462m640m764m
% profit margin10 %10 %4 %5 %8 %10 %12 %
EV / revenue4.4x3.4x2.7x2.7x2.8x2.6x2.4x
EV / EBITDA22.1x14.9x15.0x12.4x11.1x9.9x9.0x
R&D budget307m356m345m299m---
R&D % of revenue7 %7 %7 %5 %---

Source: Dealroom estimates

  • Edit
DateInvestorsAmountRound
N/A

N/A

IPO

$350m

Valuation: $350m

0.3x EV/LTM EBITDA

Acquisition
*

$204k

Post IPO Equity
Total Funding-

Recent News about Smith & Nephew

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit

Investments by Smith & Nephew

Edit
Brainlab
ACQUISITION by Smith & Nephew Jun 2019
CartiHeal
ACQUISITION by Smith & Nephew Nov 2023
OrthoSpace
ACQUISITION by Stryker Mar 2019
Arthrocare
ACQUISITION by Smith & Nephew Feb 2014
Rotation Medical
ACQUISITION by Smith & Nephew Oct 2017
Kalypto Medical
ACQUISITION by Smith & Nephew May 2012
LIFEMODELER
ACQUISITION by Smith & Nephew Apr 2012
Blue Belt Technologies
ACQUISITION by Smith & Nephew Nov 2015
View 9 more